COA VLI-BCG matches Uzorak's public record. So this test doesn't rest on our review alone — the lab confirms it too.
VLI-BCGNot on file for this certificate: endotoxins, sterility and heavy metals. A purity figure says nothing about those.
Label 80 mg · Lab measured 95.53 mg
119% of label, basis not stated — shown as printed. Reconstituted with 2 mL, a 50-unit draw holds 23.9 mg using the measured mass, against 20 mg on the label — 19% more.
One vial from this lot was weighed by the laboratory, not yours. This page reports what the certificate says; it does not recommend a dose.
| Report number | VLI-BCG |
|---|---|
| Portal lookup | ✓ Lab-verified |
| PDF vs portal | Uzorak's portal shows validity only |
| Weight | Counts as one lab test |
Independent HPLC purity analysis of GHK-Cu/TB-500/BPC-157/KPV from Nova BioLabs Peptides, performed by Uzorak on June 14, 2026. Reported purity: 99.75%. Net content: 95.53 mg against 80 mg labeled (119% of label). Tested content exceeds the labeled amount by 19%. Batch VLI-BCG. Sample source: shop-provided. Certificate of analysis attached.
| Lot | Tested | Lab | Purity | vs label | Status |
|---|---|---|---|---|---|
| NVGL70-01052026 | 14 Jun 2026 | Uzorak | 99.84% | 103% | Unverified |
| UG8-6SQ | 28 May 2026 | Uzorak | 99.85% | 97% | Unverified |
Batches this shop has published a certificate for, newest first. A lot whose printed value cannot identify a batch is not listed.
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion